ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) Net margin 2017–2025
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) net profit margin by fiscal year — reported net income divided by reported revenue.
-21.5%FY2025 · since FY2017: -111.4% → -21.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -21.5% | +67.6 pp |
| FY2024 | -89.1% | +43.2 pp |
| FY2023 | -132.3% | -24.3 pp |
| FY2022 | -108.0% | +26.3 pp |
| FY2021 | -134.3% | +14.3 pp |
| FY2020 | -148.6% | -68.0 pp |
| FY2019 | -80.6% | +2.8 pp |
| FY2018 | -83.4% | +28.0 pp |
| FY2017 | -111.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice